Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06594913 · ClinicalTrials.gov registry record
Eating Disorders Genetics Initiative 2
A clinical trial of Anorexia Nervosa and Binge-Eating Disorder, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 5
- Study locations
NCT06594913 is a study of Anorexia Nervosa and Binge-Eating Disorder that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 20,000 participants, above the 485-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (4024% higher). The trial reports 5 study locations across 4 states.
The verdict
NCT06594913, a study of Anorexia Nervosa and Binge-Eating Disorder, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new participants with anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), avoidant/restrictive food intake disorder (ARFID), and controls in the US, Mexico, Australia, New Zealand, Sweden, and Denmark. A primary study goal is to enroll at least 30% of participants from underrepresented groups. Participants are asked to complete a series of questionnaires and submit a saliva sample for genotyping. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.
Conditions Studied
Interventions
- OTHER Eating disorder diagnosis group
Study Locations (5)
Other
- Comenzar de Nuevo - Monterrey
- Karolinska Institutet - Stockholm
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Queensland
- QIMR Berghofer - Brisbane
Canterbury
- University of Otago - Christchurch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2024-10-28 |
| Est. Completion | 2027-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06594913
The ClinicalTrials.gov registry entry for NCT06594913 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 485-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (4024% higher). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 1 intervention - of which Eating disorder diagnosis group is the first listed.
NCT06594913 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Other, North Carolina, Queensland.
Frequently Asked Questions
What is clinical trial NCT06594913 about?
NCT06594913 is a clinical study titled "Eating Disorders Genetics Initiative 2". The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new participants with anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), avoidant/restri...
What is the current status of trial NCT06594913?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2024-10-28. Estimated completion is 2027-08-01.
What conditions does trial NCT06594913 study?
This clinical trial studies the following conditions: Anorexia Nervosa, Binge-Eating Disorder, Bulimia Nervosa, Avoidant Restrictive Food Intake Disorder.
What interventions are being tested in trial NCT06594913?
The interventions under investigation include: Eating disorder diagnosis group (OTHER).
Who is sponsoring clinical trial NCT06594913?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06594913 being conducted?
This trial has 5 study locations across North Carolina, Queensland, Canterbury. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anorexia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
RECRUITING · NA
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa
RECRUITING · NA
-
Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa
RECRUITING
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.